azelastine
CHEBI:CHEBI_2950
Definition
A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.
Chemical Information
- Molecular Formula
- C22H24ClN3O
- Molecular Mass
- 381.89800
- Charge
- 0
- SMILES
- CN1CCCC(CC1)n1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
- InChI
- InChI=1S/C22H24ClN3O/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16/h2-3,6-11,18H,4-5,12-15H2,1H3
- InChIKey
- MBUVEWMHONZEQD-UHFFFAOYSA-N
Alternative Names
- 4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one
- 4-(p-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone
- azelastina
- azelastine
- azelastinum
Drug Classification
-
t173051
-
t173267
-
tertiary amino compoundView Class →
CHEBI:50996
-
monochlorobenzenesView Class →
CHEBI:83403
-
phthalazinesView Class →
CHEBI:38768
-
t171965
-
t172633
-
t172699
-
t172986
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:2950
- DRON_00010000
- 18603
- oboInOwl#hasDbXref
- Wikipedia:Azelastine
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- core#notation
- CHEBI:2950
- listing_expiration_date
- 20241231
- route
- INTRAOCULAR
- spl_id
- ce1faa16-c6b2-46ea-8726-58f14737fea0
- package_ndc
- 62991-3200-1
- marketing_start_date
- 20120524
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- dosage_form
- SPRAY, METERED
- labeler_name
- Daito Pharmaceutical Co., Ltd
- application_number
- ANDA078621
- product_ndc
- 50090-7461
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 18603
- oboInOwl#hasDbXref
- Wikipedia:Azelastine
- oboInOwl#id
- CHEBI:2950
- generic_name
- Azelastine Hydrochloride and Fluticasone Propionate
- brand_name
- Astepro Allergy
- brand_name_base
- Astepro Allergy
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_37955
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- package_marketing_start_date
- 16-FEB-24
- package_description
- 25 g in 1 JAR (62991-3200-1)
- rxcui
- 1797884
- active_ingredient_name
- AZELASTINE HYDROCHLORIDE
- active_ingredient_strength
- 500 g/g
- unii
- 0L591QR10I
- pharm_class
- Histamine-1 Receptor Antagonist [EPC]
- manufacturer_name
- Somerset Therapeutics, LLC
- spl_set_id
- 37c40f8d-269c-4df8-8ac7-cbe78f4ca5c4
- upc
- 0370069091012
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_4730
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect15094
- owl#annotatedSource
- t173184
- owl#someValuesFrom
- t3020035